Castleark Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-40,820
| Closed | -$3.72M | – | 276 |
|
|
2023
Q2 | $3.72M | Buy |
+40,820
| New | +$3.72M | 0.17% | 136 |
|
|
2022
Q4 | – | Sell |
-57,890
| Closed | -$3.95M | – | 284 |
|
|
2022
Q3 | $3.95M | Buy |
+57,890
| New | +$3.95M | 0.22% | 115 |
|
|
2022
Q1 | – | Sell |
-53,130
| Closed | -$2.51M | – | 324 |
|
|
2021
Q4 | $2.51M | Buy |
+53,130
| New | +$2.51M | 0.09% | 177 |
|
|
2020
Q2 | – | Sell |
-147,165
| Closed | -$3.94M | – | 340 |
|
|
2020
Q1 | $3.94M | Buy |
+147,165
| New | +$3.94M | 0.23% | 119 |
|